glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight
EUR26.05
EUR53.05
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
![glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://i.ytimg.com/vi/t6CAAyoH37o/maxresdefault.jpg)
![glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://cdn.sanity.io/images/0vv8moc6/medec/11faedd4cc7afc7edb49d055d5df11bd9ac112b7-1200x822.jpg)
![glp 1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven Patients eligible for GLP-1 weight](https://cdn.arstechnica.net/wp-content/uploads/2025/11/GettyImages-2244850793.jpg)
